Zoledronate in the prevention of Paget's (ZiPP): Protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent SQSTM1-mediated Paget's disease of bone

  1. Cronin, O.
  2. Forsyth, L.
  3. Goodman, K.
  4. Lewis, S.C.
  5. Keerie, C.
  6. Walker, A.
  7. Porteous, M.
  8. Cetnarskyj, R.
  9. Ranganath, L.R.
  10. Selby, P.L.
  11. Hampson, G.
  12. Chandra, R.
  13. Ho, S.
  14. Tobias, J.H.
  15. Young-Min, S.
  16. McKenna, M.J.
  17. Crowley, R.K.
  18. Fraser, W.D.
  19. Gennari, L.
  20. Nuti, R.
  21. Brandi, M.L.
  22. Del Pino-Montes, J.
  23. Devogelaer, J.-P.
  24. Durnez, A.
  25. Isaia, G.
  26. Di Stefano, M.
  27. Guañabens, N.
  28. Blanch, J.
  29. Seibel, M.J.
  30. Walsh, J.P.
  31. Kotowicz, M.A.
  32. Nicholson, G.C.
  33. Duncan, E.L.
  34. Major, G.
  35. Horne, A.
  36. Gilchrist, N.L.
  37. Boers, M.
  38. Murray, G.D.
  39. Charnock, K.
  40. Wilkinson, D.
  41. Russell, R.G.G.
  42. Ralston, S.H.
  43. Montrer des auteurs +
Revue:
BMJ Open

ISSN: 2044-6055

Année de publication: 2019

Volumen: 9

Número: 9

Type: Article

DOI: 10.1136/BMJOPEN-2019-030689 GOOGLE SCHOLAR lock_openAccès ouvert editor